A detailed history of Rockefeller Capital Management L.P. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 1,221,602 shares of MRK stock, worth $118 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
1,221,602
Previous 1,265,102 3.44%
Holding current value
$118 Million
Previous $157 Million 11.43%
% of portfolio
0.38%
Previous 0.45%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $4.84 Million - $5.61 Million
-43,500 Reduced 3.44%
1,221,602 $139 Million
Q2 2024

Aug 12, 2024

SELL
$123.8 - $132.96 $4.43 Million - $4.75 Million
-35,750 Reduced 2.75%
1,265,102 $157 Million
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $10.2 Million - $11.9 Million
-90,492 Reduced 6.5%
1,300,852 $172 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $20.1 Million - $21.8 Million
200,274 Added 16.81%
1,391,344 $152 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $7.09 Million - $7.87 Million
68,837 Added 6.13%
1,191,070 $123 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $3.43 Million - $3.74 Million
31,590 Added 2.9%
1,122,233 $129 Million
Q1 2023

May 17, 2023

SELL
$102.94 - $114.86 $2.39 Million - $2.67 Million
-23,211 Reduced 2.08%
1,090,643 $116 Million
Q4 2022

Mar 06, 2023

BUY
$87.44 - $112.11 $2.21 Million - $2.84 Million
25,318 Added 2.33%
1,113,854 $124 Million
Q3 2022

Nov 02, 2022

BUY
$84.53 - $94.96 $17 Million - $19.1 Million
200,947 Added 22.64%
1,088,536 $93.7 Million
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $5.4 Million - $6.12 Million
64,672 Added 7.86%
887,589 $80.9 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $7.51 Million - $8.42 Million
102,128 Added 14.17%
822,917 $67.5 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $1.1 Million - $1.38 Million
15,272 Added 2.16%
720,789 $55.2 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $1.25 Million - $1.37 Million
17,426 Added 2.53%
705,517 $53 Million
Q2 2021

Aug 10, 2021

SELL
$70.31 - $77.77 $2.57 Million - $2.84 Million
-36,563 Reduced 5.05%
688,091 $53.5 Million
Q1 2021

May 11, 2021

BUY
$68.86 - $81.11 $4.09 Million - $4.82 Million
59,421 Added 8.93%
724,654 $55.9 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $2.82 Million - $3.13 Million
39,352 Added 6.29%
665,233 $54.4 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $2.66 Million - $3.02 Million
36,409 Added 6.18%
625,881 $51.9 Million
Q2 2020

Aug 12, 2020

BUY
$70.42 - $80.13 $7.28 Million - $8.28 Million
103,356 Added 21.26%
589,472 $45.6 Million
Q1 2020

May 12, 2020

BUY
$63.36 - $87.82 $7.04 Million - $9.76 Million
111,175 Added 29.65%
486,116 $37.4 Million
Q4 2019

Feb 07, 2020

BUY
$77.58 - $87.54 $1.63 Million - $1.84 Million
21,016 Added 5.94%
374,941 $34.1 Million
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $4.77 Million - $5.2 Million
62,718 Added 21.54%
353,925 $29.8 Million
Q2 2019

Aug 09, 2019

SELL
$69.84 - $81.59 $3.94 Million - $4.6 Million
-56,401 Reduced 16.23%
291,207 $24.4 Million
Q1 2019

May 10, 2019

BUY
$69.58 - $79.36 $4.82 Million - $5.49 Million
69,233 Added 24.87%
347,608 $28.9 Million
Q4 2018

Feb 12, 2019

SELL
$65.24 - $75.71 $1.47 Million - $1.7 Million
-22,501 Reduced 7.48%
278,375 $21.3 Million
Q3 2018

Nov 02, 2018

BUY
$57.69 - $67.84 $49,786 - $58,545
863 Added 0.29%
300,876 $21.3 Million
Q2 2018

Jul 31, 2018

SELL
$50.83 - $59.72 $5.65 Million - $6.64 Million
-111,182 Reduced 27.04%
300,013 $18.2 Million
Q1 2018

May 09, 2018

BUY
$50.96 - $59.23 $21 Million - $24.4 Million
411,195 New
411,195 $22.4 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.